BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11192286)

  • 1. A live attenuated West Nile virus strain as a potential veterinary vaccine.
    Lustig S; Olshevsky U; Ben-Nathan D; Lachmi BE; Malkinson M; Kobiler D; Halevy M
    Viral Immunol; 2000; 13(4):401-10. PubMed ID: 11192286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis.
    Desprès P; Combredet C; Frenkiel MP; Lorin C; Brahic M; Tangy F
    J Infect Dis; 2005 Jan; 191(2):207-14. PubMed ID: 15609230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chimeric dengue 2 PDK-53/West Nile NY99 viruses retain the phenotypic attenuation markers of the candidate PDK-53 vaccine virus and protect mice against lethal challenge with West Nile virus.
    Huang CY; Silengo SJ; Whiteman MC; Kinney RM
    J Virol; 2005 Jun; 79(12):7300-10. PubMed ID: 15919884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of chimaeric West Nile virus attenuated vaccine candidate based on the Japanese encephalitis vaccine strain SA14-14-2.
    Li XF; Zhao W; Lin F; Ye Q; Wang HJ; Yang D; Li SH; Zhao H; Xu YP; Ma J; Deng YQ; Zhang Y; Qin ED; Qin CF
    J Gen Virol; 2013 Dec; 94(Pt 12):2700-2709. PubMed ID: 24092759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single amino acid substitution in the West Nile virus nonstructural protein NS2A disables its ability to inhibit alpha/beta interferon induction and attenuates virus virulence in mice.
    Liu WJ; Wang XJ; Clark DC; Lobigs M; Hall RA; Khromykh AA
    J Virol; 2006 Mar; 80(5):2396-404. PubMed ID: 16474146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection of red-legged partridges (Alectoris rufa) against West Nile virus (WNV) infection after immunization with WNV recombinant envelope protein E (rE).
    Escribano-Romero E; Gamino V; Merino-Ramos T; Blázquez AB; Martín-Acebes MA; de Oya NJ; Gutiérrez-Guzmán AV; Escribano JM; Höfle U; Saiz JC
    Vaccine; 2013 Sep; 31(41):4523-7. PubMed ID: 23933372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of an attenuated West Nile virus vaccine, live Flavivirus chimera in horses.
    Long MT; Gibbs EP; Mellencamp MW; Zhang S; Barnett DC; Seino KK; Beachboard SE; Humphrey PP
    Equine Vet J; 2007 Nov; 39(6):486-90. PubMed ID: 18065304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective efficacy of a recombinant subunit West Nile virus vaccine in domestic geese (Anser anser).
    Jarvi SI; Lieberman MM; Hofmeister E; Nerurkar VR; Wong T; Weeks-Levy C
    Vaccine; 2008 Oct; 26(42):5338-44. PubMed ID: 18723064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single immunization with a minute dose of a lentiviral vector-based vaccine is highly effective at eliciting protective humoral immunity against West Nile virus.
    Iglesias MC; Frenkiel MP; Mollier K; Souque P; Despres P; Charneau P
    J Gene Med; 2006 Mar; 8(3):265-74. PubMed ID: 16308885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. West Nile virus vaccines.
    Hall RA; Khromykh AA
    Expert Opin Biol Ther; 2004 Aug; 4(8):1295-305. PubMed ID: 15268663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy, duration, and onset of immunogenicity of a West Nile virus vaccine, live Flavivirus chimera, in horses with a clinical disease challenge model.
    Long MT; Gibbs EP; Mellencamp MW; Bowen RA; Seino KK; Zhang S; Beachboard SE; Humphrey PP
    Equine Vet J; 2007 Nov; 39(6):491-7. PubMed ID: 18065305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA vaccines encoding the envelope protein of West Nile virus lineages 1 or 2 administered intramuscularly, via electroporation and with recombinant virus protein induce partial protection in large falcons (Falco spp.).
    Fischer D; Angenvoort J; Ziegler U; Fast C; Maier K; Chabierski S; Eiden M; Ulbert S; Groschup MH; Lierz M
    Vet Res; 2015 Aug; 46(1):87. PubMed ID: 26282836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chimeric West Nile/dengue virus vaccine candidate: preclinical evaluation in mice, geese and monkeys for safety and immunogenicity.
    Pletnev AG; Swayne DE; Speicher J; Rumyantsev AA; Murphy BR
    Vaccine; 2006 Sep; 24(40-41):6392-404. PubMed ID: 16831498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection provided by a recombinant ALVAC(®)-WNV vaccine expressing the prM/E genes of a lineage 1 strain of WNV against a virulent challenge with a lineage 2 strain.
    Minke JM; Siger L; Cupillard L; Powers B; Bakonyi T; Boyum S; Nowotny N; Bowen R
    Vaccine; 2011 Jun; 29(28):4608-12. PubMed ID: 21549780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An inactivated West Nile virus vaccine for domestic geese-efficacy study and a summary of 4 years of field application.
    Samina I; Khinich Y; Simanov M; Malkinson M
    Vaccine; 2005 Sep; 23(41):4955-8. PubMed ID: 16023273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host-range restriction of chimeric yellow fever-West Nile vaccine in fish crows (Corvus ossifragus).
    Langevin SA; Arroyo J; Monath TP; Komar N
    Am J Trop Med Hyg; 2003 Jul; 69(1):78-80. PubMed ID: 12932102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a human live attenuated West Nile infectious DNA vaccine: Suitability of attenuating mutations found in SA14-14-2 for WN vaccine design.
    Yamshchikov V; Manuvakhova M; Rodriguez E
    Virology; 2016 Jan; 487():198-206. PubMed ID: 26545140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination of captive nēnē (Branta sandvicensis) against West Nile virus using a protein-based vaccine (WN-80E).
    Jarvi SI; Hu D; Misajon K; Coller BA; Wong T; Lieberman MM
    J Wildl Dis; 2013 Jan; 49(1):152-6. PubMed ID: 23307381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Newcastle disease virus-vectored West Nile fever vaccine is immunogenic in mammals and poultry.
    Wang J; Yang J; Ge J; Hua R; Liu R; Li X; Wang X; Shao Y; Sun E; Wu D; Qin C; Wen Z; Bu Z
    Virol J; 2016 Jun; 13():109. PubMed ID: 27342050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A West Nile virus (WNV) recombinant canarypox virus vaccine elicits WNV-specific neutralizing antibodies and cell-mediated immune responses in the horse.
    El Garch H; Minke JM; Rehder J; Richard S; Edlund Toulemonde C; Dinic S; Andreoni C; Audonnet JC; Nordgren R; Juillard V
    Vet Immunol Immunopathol; 2008 Jun; 123(3-4):230-9. PubMed ID: 18372050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.